Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Huntington’s disease (HD) is an incurable, devastating neurodegenerative disease with a known genetic background and autosomally dominant inheritance pattern. HTT gene mutation (mHTT) is associated with polymorphic fragment elongation above 35 repeats of the CAG triplet. The mHTT product is an altered protein with a poly-Q elongated fragment, with the highest expression determined in the central nervous system (CNS) and with differentiated expression outside the CNS. A drastic loss of striatal and deeper layers of the cerebral cortex neurons was determined in the CNS, but muscle and body weight mass loss with dysfunction of many organs was also observed. HD symptoms include neurological disturbances, such as choreal movements with dystonia, speech and swallowing impairments, and additionally a variety of psychiatric and behavioral symptoms with cognitive decline have been described.They are the result of disturbances of several cellular pathways related to signal transmission, mitochondrial dysfunction and energy metabolism impairment shown by gene and protein expression and alteration of their functions. Impairment of energy processes demonstrated by a decrease of ATP production and increase of oxidative stress markers was determined in- and outside of the CNS in glycolysis, the Krebs cycle and the electron transport chain. A correlation between the increase of energy metabolism impairment level and the increase in number of CAG repeats in HTT has often been described. The energy metabolism study is an initial stage of sensitive biomarkers and a new therapeutic investigative option for early application in order to inhibit pathological processes in HD.Identification of pathological changes outside the CNS requires a reevaluation of diagnostic and therapeutic rules in HD.

Authors and Affiliations

Jolanta Krzysztoń-Russjan

Keywords

Related Articles

Bacterial type I topoisomerases – biological function and potential use as targets for antibiotic treatments

The bacterial chromosome is composed of topologically independent domains, whose spatial organization is controlled by enzymes called topoisomerases. Topology maintenance is crucial in many important cellular processes s...

Seladin-1/DHCR24: A key protein of cell homeostasis and cholesterol biosynthesis

Seladin-1 is a multifunctional protein encoded by DHCR24 gene and due to its enzymatic, antioxidant, and anti-apoptotic activities, it is considered as neuroprotective agent. Seladin-1 was identified as a gene down-regul...

The role of manganese in etiopathogenesis and prevention of selected diseases

Manganese (Mn) is an essential trace element, necessary for development and growth of the organism. The adequate content of this element in the body determines proper metabolism of amino acids, cholesterol and carbohydr...

Surgical excision of extensive anal condylomata is a safe operation without risk of anal stenosis

Introduction: Anal condylomata acuminata was a well-known disease in ancient times but in recent years there has been a rapidly increasing number of people who suffer from this disease. The main cause of this disease is...

Download PDF file
  • EP ID EP206142
  • DOI -
  • Views 174
  • Downloads 0

How To Cite

Jolanta Krzysztoń-Russjan (2016). Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease. Advances in Hygiene and Experimental Medicine, 70(), 1331-1342. https://europub.co.uk./articles/-A-206142